Stock comparison
Genmab A/S
GMAB$17.58BHealthcare Market cap, Sector
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$106.55BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
GMAB 07 SANOFICONR.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
GMAB0wins
7winsSANOFICONR.NS
70B
B78
68C
A89
49D
B83
29F
B77
82B
A91
75B
A86
74B
A85
Side-by-side metrics
| Metric | GMAB | SANOFICONR.NS |
|---|---|---|
| Market cap | $17.58B | $106.55B Winner |
| P/E (TTM) | Winner: 6.1x | 44.2x |
| EV/EBIT | Winner: 15.9x | 31.8x |
| ROIC (TTM) | 43.78% | 59.15% Winner |
| Gross margin | Winner: 93.88% | 68.13% |
| Net margin | 18.23% | 27.35% Winner |
| Revenue CAGR 5y | -18.45% | 27.01% Winner |
| EPS CAGR 5y | -23.48% | 20.67% Winner |
| Debt / Equity | 0.9x | 0.1x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GMAB leads on
- P/E (TTM)6.1xvs 44.2x+86%
- EV/EBIT15.9xvs 31.8x+50%
- Gross margin93.88%vs 68.13%+27%
SANOFICONR.NS leads on
- EPS CAGR 5y20.67%vs -23.48%+188%
- Revenue CAGR 5y27.01%vs -18.45%+168%
- Debt / Equity0.1xvs 0.9x+93%
- Market cap$106.55Bvs $17.58B+83%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.